title: Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.
authors.affiliation: Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK. brian.wilson@ncl.ac.uk.|Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, International Centre for Life, Newcastle upon Tyne, UK.
authors.forename: Brian T
authors.initials: BT
authors.lastname: Wilson
authors.affiliation: Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Cordell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics; D002296:Carcinosarcoma / Q000453:epidemiology* / Q000235:genetics; D015331:Cohort Studies; D004739:England / Q000453:epidemiology; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020249:Hormone Replacement Therapy / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D018200:Mixed Tumor, Mullerian / Q000453:epidemiology* / Q000235:genetics; D009154:Mutation / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D014594:Uterine Neoplasms / Q000453:epidemiology* / Q000235:genetics